{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:13:22Z","timestamp":1778883202385,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771633"],"award-info":[{"award-number":["81771633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572324"],"award-info":[{"award-number":["81572324"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.omto.2020.09.008","type":"journal-article","created":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T01:26:09Z","timestamp":1601774769000},"page":"149-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["S119N Mutation of the E3\u00a0Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression"],"prefix":"10.1016","volume":"19","author":[{"given":"Weijing","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongbao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuiran","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2020.09.008_bib1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00383-019-04563-5","article-title":"Epidermal growth factor receptor\/heme oxygenase-1 axis is involved in chemoresistance to cisplatin and pirarubicin in HepG2 cell lines and hepatoblastoma specimens","volume":"35","author":"Kobayashi","year":"2019","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.omto.2020.09.008_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1093526619875228","article-title":"Hepatoblastoma and pediatric hepatocellular carcinoma: an update","volume":"23","author":"Ranganathan","year":"2020","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.omto.2020.09.008_bib3","doi-asserted-by":"crossref","first-page":"8517","DOI":"10.2147\/CMAR.S213707","article-title":"Long noncoding RNA PVT1 promotes hepatoblastoma cell proliferation through activating STAT3","volume":"11","author":"Luo","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.omto.2020.09.008_bib4","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1038\/s41467-019-11533-x","article-title":"GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGF\u03b2 signaling","volume":"10","author":"Matsumoto","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omto.2020.09.008_bib5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/cancers11101406","article-title":"The emerging roles of cancer stem cells and Wnt\/beta-catenin signaling in hepatoblastoma","volume":"11","author":"Mavila","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2020.09.008_bib6","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/hep.27243","article-title":"Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex","volume":"60","author":"Jia","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.omto.2020.09.008_bib7","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192466","article-title":"Wnt\/\u03b2-catenin signaling as a useful therapeutic target in hepatoblastoma","volume":"39","author":"Sha","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.omto.2020.09.008_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41419-019-1943-0","article-title":"DPEP1 is a direct target of miR-193a-5p and promotes hepatoblastoma progression by PI3K\/Akt\/mTOR pathway","volume":"10","author":"Cui","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omto.2020.09.008_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.freeradbiomed.2015.11.022","article-title":"Momordin Ic couples apoptosis with autophagy in human hepatoblastoma cancer cells by reactive oxygen species (ROS)-mediated PI3K\/Akt and MAPK signaling pathways","volume":"90","author":"Mi","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.omto.2020.09.008_bib10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/ped.13634","article-title":"Avoiding liver transplantation in post-treatment extent of disease III and IV hepatoblastoma","volume":"60","author":"El-Gendi","year":"2018","journal-title":"Pediatr. Int. (Roma)"},{"key":"10.1016\/j.omto.2020.09.008_bib11","doi-asserted-by":"crossref","first-page":"e26820","DOI":"10.1002\/pbc.26820","article-title":"Extreme hepatic resections for the treatment of advanced hepatoblastoma: are planned close margins an acceptable approach?","volume":"65","author":"Fonseca","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.omto.2020.09.008_bib12","doi-asserted-by":"crossref","first-page":"e27383","DOI":"10.1002\/pbc.27383","article-title":"Surgical treatment strategy for advanced hepatoblastoma: resection versus transplantation","volume":"65","author":"Uchida","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.omto.2020.09.008_bib13","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","article-title":"Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study","volume":"28","author":"Zs\u00edros","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omto.2020.09.008_bib14","first-page":"553","article-title":"The role of surgical treatment in the multidisciplinary therapy for hepatoblastoma","volume":"61","author":"Yada","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.omto.2020.09.008_bib15","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/MPH.0000000000001171","article-title":"Addition of vincristine and irinotecan to standard therapy in a patient with refractory high-risk hepatoblastoma achieving long-term relapse-free survival","volume":"41","author":"Powers","year":"2019","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.omto.2020.09.008_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00383-018-4250-4","article-title":"Right trisegmentectomy after portal vein embolization in a high-risk toddler with hepatoblastoma","volume":"34","author":"Le","year":"2018","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.omto.2020.09.008_bib17","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1080\/15384047.2016.1235664","article-title":"Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma","volume":"17","author":"Beck","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.omto.2020.09.008_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0030-1262798","article-title":"High-risk hepatoblastoma: results in a pediatric liver transplantation center","volume":"21","author":"Barrena","year":"2011","journal-title":"Eur. J. Pediatr. Surg."},{"key":"10.1016\/j.omto.2020.09.008_bib19","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/cncr.30591","article-title":"Upfront window vincristine\/irinotecan treatment of high-risk hepatoblastoma: a report from the Children\u2019s Oncology Group AHEP0731 study committee","volume":"123","author":"Katzenstein","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.omto.2020.09.008_bib20","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/pros.23830","article-title":"SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer","volume":"79","author":"Hern\u00e1ndez-Llodr\u00e0","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.omto.2020.09.008_bib21","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1111\/febs.15056","article-title":"The ubiquitin ligase adaptor SPOP in cancer","volume":"286","author":"Cuneo","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.omto.2020.09.008_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.devcel.2018.11.033","article-title":"AMPK promotes SPOP-mediated NANOG degradation to regulate prostate cancer cell stemness","volume":"48","author":"Wang","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omto.2020.09.008_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2018.11.035","article-title":"SPOP promotes Nanog destruction to suppress stem cell traits and prostate cancer progression","volume":"48","author":"Zhang","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omto.2020.09.008_bib24","doi-asserted-by":"crossref","first-page":"e10659","DOI":"10.15252\/emmm.201910659","article-title":"The novel BET-CBP\/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer","volume":"11","author":"Yan","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omto.2020.09.008_bib25","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1038\/s41467-018-07475-5","article-title":"TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression","volume":"9","author":"Fong","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omto.2020.09.008_bib26","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/onc.2017.80","article-title":"SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein","volume":"36","author":"Geng","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.omto.2020.09.008_bib27","doi-asserted-by":"crossref","first-page":"e17439","DOI":"10.1097\/MD.0000000000017439","article-title":"The association of speckle-type POZ protein with lymph node metastasis and prognosis in cancer patients: A meta-analysis","volume":"98","author":"Cheng","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.omto.2020.09.008_bib28","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.drudis.2014.07.009","article-title":"The emerging role of speckle-type POZ protein (SPOP) in cancer development","volume":"19","author":"Mani","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omto.2020.09.008_bib29","doi-asserted-by":"crossref","first-page":"21191","DOI":"10.1073\/pnas.0912008106","article-title":"Multiple Ser\/Thr-rich degrons mediate the degradation of Ci\/Gli by the Cul3-HIB\/SPOP E3 ubiquitin ligase","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2020.09.008_bib30","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41598-017-04965-2","article-title":"The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B","volume":"7","author":"Chafai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omto.2020.09.008_bib31","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jcb.23022","article-title":"CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines","volume":"112","author":"Abdelmagid","year":"2011","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.omto.2020.09.008_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/rna.1.2.1066","article-title":"miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1","volume":"1","author":"Chang","year":"2004","journal-title":"RNA Biol."},{"key":"10.1016\/j.omto.2020.09.008_bib33","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/1873-3468.13482","article-title":"Mutations in TOP2B cause autosomal-dominant hereditary hearing loss via inhibition of the PI3K-Akt signalling pathway","volume":"593","author":"Xia","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omto.2020.09.008_bib34","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1002\/jcp.29331","article-title":"Novel LRAP-binding partner revealing the plasminogen activation system as a regulator of cementoblast differentiation and mineral nodule formation in\u00a0vitro","volume":"235","author":"Martins","year":"2020","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.omto.2020.09.008_bib35","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1038\/s41467-018-07185-y","article-title":"Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omto.2020.09.008_bib36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature22314","article-title":"Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia","volume":"545","author":"Hattori","year":"2017","journal-title":"Nature"}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520301479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520301479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:35:05Z","timestamp":1778880905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770520301479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":36,"alternative-id":["S2372770520301479"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2020.09.008","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S119N Mutation of the E3\u00a0Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2020.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}